Aliphatically substituted pyrazolopyridines, and the use thereof

US8334291B2 · kind B2 · utility

Assignee

• Bayer Intellectual Property GmbH · DE

Inventors

• Hartmut Schirok · Wuppertal, DE
• Nils Griebenow · Milford, US
• Chantal Fürstner · Neheim, DE
• Joachim Mittendorf · Wuppertal, DE
• Johannes-Peter Stasch · Wuppertal, DE
• Frank Wunder · Wuppertal, DE
• Stefan Heitmeier · Wülfrath, DE

Key dates

• Filing date: Dec 8, 2009
• Grant date: Dec 18, 2012
• Expiry date: Dec 8, 2029

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present application relates to novel aliphatically substituted pyrazolopyridines, to processes for their preparation, to their use, alone or in combination, for the treatment and/or prevention of diseases and to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of cardiovascular disorders.